122 related articles for article (PubMed ID: 14599359)
1. Phage display of functional human TNF-alpha converting enzyme catalytic domain: a rapid method for the production of stabilized proteolytic proteins for assay development and high-throughput screening.
Chen Y; Diener K; Patel IR; Kawooya JK; Martin GA; Yamdagni P; Zhang X; Sandrasalphaa A; Sahasrabudhe S; Busch SJ
J Biomol Screen; 2002 Oct; 7(5):433-40. PubMed ID: 14599359
[TBL] [Abstract][Full Text] [Related]
2. Identification and characterization of 4-[[4-(2-butynyloxy)phenyl]sulfonyl]-N-hydroxy-2,2-dimethyl-(3S)thiomorpholinecarboxamide (TMI-1), a novel dual tumor necrosis factor-alpha-converting enzyme/matrix metalloprotease inhibitor for the treatment of rheumatoid arthritis.
Zhang Y; Xu J; Levin J; Hegen M; Li G; Robertshaw H; Brennan F; Cummons T; Clarke D; Vansell N; Nickerson-Nutter C; Barone D; Mohler K; Black R; Skotnicki J; Gibbons J; Feldmann M; Frost P; Larsen G; Lin LL
J Pharmacol Exp Ther; 2004 Apr; 309(1):348-55. PubMed ID: 14718605
[TBL] [Abstract][Full Text] [Related]
3. Engineering N-terminal domain of tissue inhibitor of metalloproteinase (TIMP)-3 to be a better inhibitor against tumour necrosis factor-alpha-converting enzyme.
Lee MH; Verma V; Maskos K; Nath D; Knäuper V; Dodds P; Amour A; Murphy G
Biochem J; 2002 May; 364(Pt 1):227-34. PubMed ID: 11988096
[TBL] [Abstract][Full Text] [Related]
4. Substrate specificity and novel selective inhibitors of TNF-alpha converting enzyme (TACE) from two-dimensional substrate mapping.
Lambert MH; Blackburn RK; Seaton TD; Kassel DB; Kinder DS; Leesnitzer MA; Bickett DM; Warner JR; Andersen MW; Badiang JG; Cowan DJ; Gaul MD; Petrov KG; Rabinowitz MH; Wiethe RW; Becherer JD; McDougald DL; Musso DL; Andrews RC; Moss ML
Comb Chem High Throughput Screen; 2005 Jun; 8(4):327-39. PubMed ID: 16101009
[TBL] [Abstract][Full Text] [Related]
5. [Screening of TACE peptide inhibitors from a phage display random 15-peptide library by recombinant TACE ecotodomain].
Huang W; Li LB; Han L; Zhang H; Yang YZ
Sheng Wu Gong Cheng Xue Bao; 2005 Jan; 21(1):30-5. PubMed ID: 15859325
[TBL] [Abstract][Full Text] [Related]
6. Ectodomain shedding of TNF-alpha is enhanced by nardilysin via activation of ADAM proteases.
Hiraoka Y; Yoshida K; Ohno M; Matsuoka T; Kita T; Nishi E
Biochem Biophys Res Commun; 2008 May; 370(1):154-8. PubMed ID: 18355445
[TBL] [Abstract][Full Text] [Related]
7. TNF-alpha convertase enzyme from human arthritis-affected cartilage: isolation of cDNA by differential display, expression of the active enzyme, and regulation of TNF-alpha.
Patel IR; Attur MG; Patel RN; Stuchin SA; Abagyan RA; Abramson SB; Amin AR
J Immunol; 1998 May; 160(9):4570-9. PubMed ID: 9574564
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the tumor necrosis factor-alpha-converting enzyme by its pro domain.
Gonzales PE; Solomon A; Miller AB; Leesnitzer MA; Sagi I; Milla ME
J Biol Chem; 2004 Jul; 279(30):31638-45. PubMed ID: 15100227
[TBL] [Abstract][Full Text] [Related]
9. Screening of TACE peptide inhibitors from phage display peptide library.
Huang W; Li L; Han L; Yang Y
J Huazhong Univ Sci Technolog Med Sci; 2005; 25(5):473-6. PubMed ID: 16463648
[TBL] [Abstract][Full Text] [Related]
10. Pronounced diversity in electronic and chemical properties between the catalytic zinc sites of tumor necrosis factor-alpha-converting enzyme and matrix metalloproteinases despite their high structural similarity.
Solomon A; Rosenblum G; Gonzales PE; Leonard JD; Mobashery S; Milla ME; Sagi I
J Biol Chem; 2004 Jul; 279(30):31646-54. PubMed ID: 15102849
[TBL] [Abstract][Full Text] [Related]
11. Functional analysis of the domain structure of tumor necrosis factor-alpha converting enzyme.
Reddy P; Slack JL; Davis R; Cerretti DP; Kozlosky CJ; Blanton RA; Shows D; Peschon JJ; Black RA
J Biol Chem; 2000 May; 275(19):14608-14. PubMed ID: 10799547
[TBL] [Abstract][Full Text] [Related]
12. Expression and purification of correctly processed, active human TACE catalytic domain in Saccharomyces cerevisiae.
Clarke HR; Wolfson MF; Rauch CT; Castner BJ; Huang CP; Gerhart MJ; Johnson RS; Cerretti DP; Paxton RJ; Price VL; Black RA
Protein Expr Purif; 1998 Jun; 13(1):104-10. PubMed ID: 9631522
[TBL] [Abstract][Full Text] [Related]
13. Multiple metalloproteinases process protransforming growth factor-alpha (proTGF-alpha).
Hinkle CL; Mohan MJ; Lin P; Yeung N; Rasmussen F; Milla ME; Moss ML
Biochemistry; 2003 Feb; 42(7):2127-36. PubMed ID: 12590602
[TBL] [Abstract][Full Text] [Related]
14. Definition of peptide inhibitors from a synthetic peptide library by targeting gelatinase B/matrix metalloproteinase-9 (MMP-9) and TNF-α converting enzyme (TACE/ADAM-17).
Qiu Z; Yan M; Li Q; Liu D; Van den Steen PE; Wang M; Opdenakker G; Hu J
J Enzyme Inhib Med Chem; 2012 Aug; 27(4):533-40. PubMed ID: 21827363
[TBL] [Abstract][Full Text] [Related]
15. TNF-alpha converting enzyme (TACE) is inhibited by TIMP-3.
Amour A; Slocombe PM; Webster A; Butler M; Knight CG; Smith BJ; Stephens PE; Shelley C; Hutton M; Knäuper V; Docherty AJ; Murphy G
FEBS Lett; 1998 Sep; 435(1):39-44. PubMed ID: 9755855
[TBL] [Abstract][Full Text] [Related]
16. Reactive oxygen species mediate tumor necrosis factor alpha-converting, enzyme-dependent ectodomain shedding induced by phorbol myristate acetate.
Zhang Z; Oliver P; Lancaster JR; Schwarzenberger PO; Joshi MS; Cork J; Kolls JK
FASEB J; 2001 Feb; 15(2):303-5. PubMed ID: 11156944
[TBL] [Abstract][Full Text] [Related]
17. The tumor necrosis factor-alpha converting enzyme (TACE): a unique metalloproteinase with highly defined substrate selectivity.
Mohan MJ; Seaton T; Mitchell J; Howe A; Blackburn K; Burkhart W; Moyer M; Patel I; Waitt GM; Becherer JD; Moss ML; Milla ME
Biochemistry; 2002 Jul; 41(30):9462-9. PubMed ID: 12135369
[TBL] [Abstract][Full Text] [Related]
18. Specific sequence elements are required for the expression of functional tumor necrosis factor-alpha-converting enzyme (TACE).
Milla ME; Leesnitzer MA; Moss ML; Clay WC; Carter HL; Miller AB; Su JL; Lambert MH; Willard DH; Sheeley DM; Kost TA; Burkhart W; Moyer M; Blackburn RK; Pahel GL; Mitchell JL; Hoffman CR; Becherer JD
J Biol Chem; 1999 Oct; 274(43):30563-70. PubMed ID: 10521439
[TBL] [Abstract][Full Text] [Related]
19. Tumour necrosis factor alpha converting enzyme (TACE) activity in the colonic mucosa of patients with inflammatory bowel disease.
Brynskov J; Foegh P; Pedersen G; Ellervik C; Kirkegaard T; Bingham A; Saermark T
Gut; 2002 Jul; 51(1):37-43. PubMed ID: 12077089
[TBL] [Abstract][Full Text] [Related]
20. Microparticles of human atherosclerotic plaques enhance the shedding of the tumor necrosis factor-alpha converting enzyme/ADAM17 substrates, tumor necrosis factor and tumor necrosis factor receptor-1.
Canault M; Leroyer AS; Peiretti F; Lesèche G; Tedgui A; Bonardo B; Alessi MC; Boulanger CM; Nalbone G
Am J Pathol; 2007 Nov; 171(5):1713-23. PubMed ID: 17872973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]